High Specificity of sIgE to α−/β‐Gliadin and Limited Reactivity to Non‐Gluten Proteins in Wheat Allergy Dependent on Augmentation Factors ( WALDA )

BACKGROUND: Wheat allergy dependent on augmentation factors (WALDA) represents the most common form of IgE-mediated wheat allergy in adults. Although ω5-gliadin is the major allergen in WALDA, sIgE reactivity to non-gluten wheat proteins remains poorly characterized. METHODS: Serum samples from 54 adults with challenge-confirmed WALDA and 21 tolerant controls (including 5 with positive sIgE to ω5-gliadin) from two German centres were analysed for sIgE reactivity to 19 recombinant wheat proteins and the cross-reactive carbohydrate determinant (CCD) MUXF3. RESULTS: sIgE to α-/β-gliadin (Tri a 21.0101) was highly specific for WALDA, present in 29/54 patients (53.7%) but absent in controls (100% specificity, p < 0.001). Receiver operating characteristic analysis revealed excellent discriminatory ability (area under the curve = 0.85) with an optimal cut-off of 0.22 kU/l. Reactivity to non-gluten wheat proteins was limited, with 24.1% of patients showing sIgE to thioredoxin, 11.3% to dehydrin, 9.3% to any α-amylase/trypsin inhibitor subunit, and minimal sIgE to non-specific lipid transfer proteins (Tri a 14), thiol reductase, triosephosphate isomerase, peroxiredoxin, serpin, glyceraldehyde-3-phosphate dehydrogenase, serine protease inhibitor-like allergen, and peroxidase. Non-gluten reactivity correlated strongly with MUXF3 CCD (ρ = 0.776), total IgE (ρ = 0.646), and wheat extract sIgE (ρ = 0.534; all p < 0.001). Grass pollen-sensitized individuals showed increased non-gluten protein reactivity (p < 0.001). Controls demonstrated higher MUXF3 CCD reactivity (38.1% vs. 11.6%, p < 0.05). CONCLUSION: The data suggest that WALDA is characterized by highly specific reactivity to gliadin proteins, with limited sensitization to non-gluten wheat components. sIgE to α-/β-gliadin represents a promising diagnostic biomarker with superior specificity compared with ω5-gliadin alone.

Authors

Institutions

Publication Details

Journal
Clinical & Experimental Allergy
Published
2026-09-11
DOI
https://doi.org/10.1111/cea.70429
Primary Topic
Celiac Disease Research and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

High Specificity of sIgE to α−/β‐Gliadin and Limited Reactivity to Non‐Gluten Proteins in Wheat Allergy Dependent on Augmentation Factors ( WALDA )

Knut Brockow, Valentina Faihs, Monika Raulf, Margitta Worm et al.
Clinical & Experimental Allergy
Celiac Disease Research and Management
article

High Specificity of sIgE to α−/β‐Gliadin and Limited Reactivity to Non‐Gluten Proteins in Wheat Allergy Dependent on Augmentation Factors ( WALDA )

Knut Brockow, Valentina Faihs, Monika Raulf, Margitta Worm, Claudia Kugler, Ingrid Sander, Tilo Biedermann, Florian Schusta
article en

Abstract

BACKGROUND: Wheat allergy dependent on augmentation factors (WALDA) represents the most common form of IgE-mediated wheat allergy in adults. Although ω5-gliadin is the major allergen in WALDA, sIgE reactivity to non-gluten wheat proteins remains poorly characterized. METHODS: Serum samples from 54 adults with challenge-confirmed WALDA and 21 tolerant controls (including 5 with positive sIgE to ω5-gliadin) from two German centres were analysed for sIgE reactivity to 19 recombinant wheat proteins and the cross-reactive carbohydrate determinant (CCD) MUXF3. RESULTS: sIgE to α-/β-gliadin (Tri a 21.0101) was highly specific for WALDA, present in 29/54 patients (53.7%) but absent in controls (100% specificity, p < 0.001). Receiver operating characteristic analysis revealed excellent discriminatory ability (area under the curve = 0.85) with an optimal cut-off of 0.22 kU/l. Reactivity to non-gluten wheat proteins was limited, with 24.1% of patients showing sIgE to thioredoxin, 11.3% to dehydrin, 9.3% to any α-amylase/trypsin inhibitor subunit, and minimal sIgE to non-specific lipid transfer proteins (Tri a 14), thiol reductase, triosephosphate isomerase, peroxiredoxin, serpin, glyceraldehyde-3-phosphate dehydrogenase, serine protease inhibitor-like allergen, and peroxidase. Non-gluten reactivity correlated strongly with MUXF3 CCD (ρ = 0.776), total IgE (ρ = 0.646), and wheat extract sIgE (ρ = 0.534; all p < 0.001). Grass pollen-sensitized individuals showed increased non-gluten protein reactivity (p < 0.001). Controls demonstrated higher MUXF3 CCD reactivity (38.1% vs. 11.6%, p < 0.05). CONCLUSION: The data suggest that WALDA is characterized by highly specific reactivity to gliadin proteins, with limited sensitization to non-gluten wheat components. sIgE to α-/β-gliadin represents a promising diagnostic biomarker with superior specificity compared with ω5-gliadin alone.

Clinical & Experimental Allergy
Odense University Hospital (DK), TUM Klinikum (DE), Humboldt-Universität zu Berlin (DE), Institute for Prevention and Occupational Medicine (DE)
Deutsche Forschungsgemeinschaft
Reduced inequalities
Openalex Percentile: Top 9%
Celiac Disease Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.